Functional Food Products with Antihypertensive Effects

Bioactive Proteins and Peptides as Functional Foods and Nutraceuticals

Volumn , Issue , 2010, Pages 169-177

  Yamamoto, Naoyuki ^a  

^a CALPIS Co Ltd   (Japan)

Author keywords

"foods for specified health use" (FOSHU) by Ministry of Health and Welfare of Japan; ACE inhibitory effects; Antihypertensive peptides, fermented milk products and enzymatic hydrolysis of food proteins; Antihypertensive peptides, from caseins by proteolytic action; Functional food products in market; Functional food products with antihypertensive effects; Peptide absorption; Potent ACEI peptides, by in vitro test antihypertensive effects in SHR; Spontaneously hypertensive rat (SHR) animal model evaluating antihypertensive activity of selected ACEI peptides

Indexed keywords

EID: 84886478361     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780813811048.ch12     Document Type: Chapter

References (72)

1. Adibi SA. 1971. Intestinal transport of dipeptides in man: Relative importance of hydrolysis and intact absorption. J Clin Invest 50: 2266.
2. Amhar A, Saito T, Aimar MV, Itoh T. 1996. New derivation of the inhibitory activity against angiotensin converting enzyme (ACE) from sweet cheese whey. J Agric Res 47: 1.
3. Bellamy W, Takase M, Yamauchi K, Shimamura S, Tomita M. 1992. Identification of the bactericidal domain of lactoferrin. Biochim Biophis Acta 1121: 130.
4. Caldwell PR, Seegal BC, Hsu KC, Das M, Soffer RL. 1976. Angiotensin-converting enzyme: Vascular endothelial localization . Science 191: 1050.
5. Defendini R, Zimmerman EA, Weare JA, Alhenc-Gelas F, Erdös EG. 1983. Angiotensin-converting enzyme in epithelial and neuroepithelial cells. Neuroendocrinology 37: 32.
6. El-Dorry HA, Bull HG, Iwata K, Thornberry NA, Cordes EH, Sofffer RL. 1982. Molecular and catalytic properties of rabbit testicular dipeptidyl carboxypeptidase. J Biol Chem 257: 14128.
7. Erdös EG, Skidgel RA. 1987. The angiotensin I-converting enzyme. Lab Invest 56: 345.
8. Ferreira SH, Bartelt DC, Greene LJ. 1970. Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry 9: 2583.
9. FitzGerald RJ. 1998. Potential uses of caseinophosphopeptides. Intl Dairy J 8: 451.
10. Foltz M, Meynen EE, Bianco V, van Platerink C, Koning TMMG, Kloek J. 2007. Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation. J Nutr 137: 953.
11. Fujimura A, Kajiyama H, Ebihara A, Iwashita K, Nomura Y, Kawahara Y. 1986. Pharmacokinetics and pharmacodynamics of captopril in patients undergoing continuous ambulatory peritoneal dialysis. Nephron 44: 324.
12. Fujita H, Yokoyama K, Yoshikawa M. 2000. Classification and antihypertensive activity of angiotensin I-converting enzyme inhibitory peptides derived from food proteins. J Food Sci 65: 564.
13. Fujita H, Yoshikawa M. 1999. LKPNM: A prodrug-type ACE-inhibitory peptide derived from fish protein. Immunopharmacology 15: 123.
14. Gobbetti M, Ferranti P, Smacchi E, Gofredi F, Addeo F. 2000. Production of angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4. Appl Environ Microbiol 66: 3898.
15. Hara H, Funabiki R, Iwata M, Yamazaki K. 1984. Portal absorption of small peptides in rats under unrestrained conditions. J Nutr 114: 1122.
16. Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T. 1996. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Amer J Clin Nutr 64: 767.
17. Ikemoto F, Tanaka M, Ito S, Song GB, Tominaga M, Hiruma M, Takada T, Nakamura N, Yamamoto K. 1986. Angiotensin converting enzyme (ACE) in the kidney: Contribution to blood pressure regulation and possible role of brush-border ACE. J Cardiovasc Pharmacol 8: 69.
18. Jin H, Yang R, Awad AT, Wang F, Li W, Williams SP, Ogasawara A, Shimada B, Williams M, Feo de G, Paoni NF. 2001. Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction. Circulation 103: 736.
19. Karaki H, Doi K, Sugino S, Uchiwa H, Sugai R, Murakami U, Takemoto S. 1990. Antihypertensive effect of tryptic hydrolysate of milk casein in spontaneously hypertensive rats. Comp Biochem Physiol 96: 367.
20. Kinoshita E, Yamakoshi J, Kikuchi M. 1993. Purification and identification of an angiotensin I-converting enzyme inhibitor from soy sauce. Biosci Biotech Biochem 57: 1107.
21. Kohama Y, Matsumoto S, Oka H, Terumoto T. 1988. Isolation of angiotensin-converting enzyme inhibitor from tuna muscle. Biochem Biophys Res Commun 155: 332.
22. Kohama Y, Oka H, Kayamori Y, Tsujikawa K, Mimura T, Nagase Y, Satake M. 1991. Potent synthetic analogues of angiotensin-converting enzyme inhibitor derived from tuna muscle. Agricul Biol Chem 55: 2169.
23. Kohlstedt K, Busse R, Fleming I. 2005. Signaling via the angiotensin-converting enzyme enhances the expression of cyclooxygenase-2 in endothelial cells. Hypertension 45: 126.
24. Kohmura M, Nio N, Kubo K, Minoshima Y, Munekata E, Ariyoshi Y. 1989. Inhibition of angiotensin-converting enzyme by synthetic peptides of human β-casein. Agric Biol Chem 53: 2107.
25. Loffler, BM. 2000. Endothelin-converting enzyme inhibitors: Current status and perspectives. J Cardiovasc Pharmacol 35: S79.
26. Maruyama S, Mitachi H, Awaya J, Suzuki H. 1987b. Angiotensin I-converting enzyme inhibitory activity of the c-terminal hexapeptide of α s1-casein. Agric Biol Chem 51: 2557.
27. Maruyama S, Mitachi H, Tanaka H, Tomizuka N, Suzuki H. 1987a. Studies on the active site and antihypertensive activity of angiotensin I-converting enzyme Inhibitors derived from casein. Agric Biol Chem 51: 1581.
28. Maruyama S, Miyoshi S, Kaneko T, Tanaka H. 1989. Angiotensin I-converting enzyme Inhibitory activities of synthetic peptides related to the tandem repeated sequence of a maize endosperm protein. Agricul Biol Chem 53: 1077.
29. Maruyama S, Nakagome K, Tomizuka N, Suzuki H. 1985. Angiotensin I-converting enzyme inhibitor derived from an enzymatic hydrolysate of casein. II. Isolation and bradykinin-potentiating activity on the uterus and the Ileum of rats. Agric Biol Chem 49: 1405.
30. Maruyama S, Suzuki H. 1982. A peptide inhibitor of angiotensin I converting enzyme in the tryptic hydrolysate of casein. Agric Biol Chem 46: 1393.
31. Masuda O, Nakamura Y, Takano T. 1996. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr 126: 3063.
32. Matsufuji H, Matusi T, Ohshige S, Kawasaki T, Osajima K, Osajima Y. 1995. Antihypertensive effects of angiotensin fragments in SHR. Biosci Biotech Biochem 59: 1398.
33. Matsufuji H, Matusi T, Seki E, Osajima K, Nakashima M, Osajima Y. 1994. Angiotensin I-converting enzyme inhibitory peptides in an alkaline protease hydrolyzate derived from sardine muscle. Biosci Biotech Biochem 58: 2244.
34. Matsui T, Imamura M, Oka H, Osajima K, Kimoto K, Kawasaki T, Matsumoto K. 2004. Tissue distribution of antihypertensive dipeptide, Val-Tyr, after its single oral administration to spontaneously hypertensive rats. J Pept Sci 10: 535.
35. Matsui T, Li CH, Osajima Y. 1999. Preparation and characterization of novel bioactive peptides responsible for angiotensin I-converting enzyme inhibition from wheat germ. J Pept Sci 5: 289-297.
36. Matsui T, Matsufuji H, Seki E, Osajima K, Nakashima M, Osajima Y. 1993. Inhibition of angiotensin I-converting enzyme by Bacillus licheniformis alkaline protease hydrolyzates derived from sardine muscle. Biosci Biotech Biochem 57: 922.
37. Matsui T, Tamaya K, Seki E, Osajima K, Matsumo K, Kawasaki T. 2002. Absorption of Val-Tyr with in vitro angiotensin I-converting enzyme inhibitory activity into the circulating blood system of mild hypertensive subjects. Biol Pharm Bull 25: 1228.
38. Matsumura N, Fujii M, Takeda Y, Shimizu T. 1993b. Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels. Biosci Biotech Biochem 57: 1743.
39. Matsumura N, Fujii M, Takeda Y, Sugita K, Shimizu, T. 1993a. Angiotensin I-converting enzyme inhibitory peptides derived from bonito bowels autolysate. Biosci Biotech Biochem 57: 695.
40. Meisel H. 1996. Chemical characterization and opioid activity of an exorphin isolated from in vivo digests of casein. FEBS Lett 196-223.
41. Meisel H, Bockelmann, W. 1999. Bioactive peptides encrypted in milk proteins: Proteolytic activation and thropho-functional properties. Antonie van Leewenhoek 76: 207.
42. Meyer RF, Nicolaides ED, Tinney FJ, Lunney EA, Holmes A, Hoefle, ML, Smith RD, Essenburg AD, Kaplan HR, Almquist RG. 1981. Novel synthesis of (S)-1-[5- (benzoylamino)-1,4-dioxo-6-phenylhexyl]-L-proline and analogues: Potent angiotensin converting enzyme inhibitors. J Med Chem 24: 964.
43. Migliore-Samour D, Floch F, Jollès P. 1989. Biologically active casein peptides implicated in immunomodulation. J Dairy Res 56: 357.
44. Miyoshi S, Ishikawa H, Kaneko T, Fukui F, Tanaka H, Maruyama S. 1991a. Structures and activity of angiotensin-converting enzyme inhibitors in an alpha-zein hydrolysate. Agricul Biol Chem 55: 1313.
45. Miyoshi S, Kaneko T, Yoshizawa Y, Fukui F, Tanaka H, Maruyama S. 1991b. Hypotensive activity of enzymatic α-zein hydrolyzate. Agricul Biol Chem 55: 1407-1408.
46. Nakamura Y, Masuda O, Takano T. 1996. Decrease of tissue angiotensin I-converting enzyme activity upon feeding sour milk in spontaneously hypertensive rats. Biosci Biotech Biochem 60: 488.
47. Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Takano T. 1995a. J Dairy Sci 78: 777.
48. Nakamura Y, Yamamoto N, Sakai K, Takano T. 1995b. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci 78: 1253.
49. Okamoto A, Hanagata H, Matsumoto E, Kawamura Y, Koizumi Y, Yanagida F. 1995. Angiotensin I converting enzyme inhibitory activities of various fermented foods. Biosci Biotechnol Biochem 59: 1147.
50. Ondetti MA, Williams NJ, Sabo EF, Pluscec J, Weaver ER, Kocy O. 1971. Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis. Biochemistry 10: 4033.
51. Oshima G, Shimabukuro H, Nagasawa K. 1979. Peptide inhibitors of angiotensin I-converting enzyme in digests of gelatin by bacterial collagenase. Biochim Biophys Acta 566: 128.
52. Pritchard GG, Coolbear T. 1993. The physiology and biochemistry of the proteolytic system in lactic acid bacteria. FEMS Microbiol Rev 12: 179.
53. Saito T, Abubakar A, Itoh T, Arai I, Aimar MV. 1997. Development of a new type of fermented cheese whey beverage with inhibitory effects against angiotensin converting enzyme. J Agric Res 48: 15.
54. Saito Y, Nakamura K, Kawato A, Imayasu, S. 1992. [No available Japanese title.] Nippon Nôgeikagaku Kaishi (in Japanese) 66: 1081.
55. Saito Y, Wanezaki K, Kawato A, Imayasu S. 1994. Structure and activity of angiotensin I converting enzyme inhibitory peptides from sake and sake lees. Biosci Biotech Biochem 58: 1767.
56. Seppo L, Kerojoki O, Suomalainen T, Korpela R. 2002. The effect of a Lactobacillus helveticus LBK-16 H fermented milk on hypertension-a pilot study on humans. Milchwissenschaft 57: 124.
57. Shin ZI, Yu R, Park SA, Cheng DK, Ahn CW, Nam HS, Kim KS, Lee HJ. 2001. His-His-Leu, an angiotensin I converting enzyme inhibitory peptide derived from Korean soybean paste, exerts antihypertensive activity in vivo. J Agric Food Chem 49: 3004.
58. Skeggs LT, Kahn JR, Shumway NP. 1956. The preparation and function of the hypertensin-converting enzyme. J Exp Med 103: 295.
59. Smid EJ, Poolman B, Konings WN. 1991. Casein utilization by lactococci. Appl Environ Microbiol 57: 2447.
60. Takano T. 2002. Anti-hypertensive activity of fermented dairy products containing biogenic peptides. Antonie van Leewenhoek 82: 333.
61. Tan PST, Poolman B, Konings WN. 1993. Proteolytic enzymes of Lactococcus lactis. J Dairy Res 60: 269.
62. Teschemacher H, Kock G, Brantl V. 1997. Milk protein-derived opioid receptor ligands. Biopoly 43: 99.
63. Thomas TD, Mills, OE. 1981. Proteolytic enzymes of starter bacteria. Neth Milk Dairy J 35: 255.
64. Xu JY, Qin LQ, Wang PY, Li W, Chang C. 2008. Effect of milk tripeptides on blood pressure: A meta-analysis of randomized controlled trials. Nutrition 24: 933.
65. Yamaguchi N, Kawaguchi K, Yamamoto N. 2009. Study of the mechanism of antihypertensive peptides VPP and IPP in spontaneously hypertensive rats by DNA microarray analysis. Eur J Pharmacol. 620: 71.
66. Yamamoto N. 1997. Antihypertensive peptides derived from food proteins. Biopoly 43: 129.
67. Yamamoto N, Akino A, Takano T. 1994a. Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. J Dairy Sci 77: 917.
68. Yamamoto N, Akino A, Takano T. 1994b. Antihypertensive effects of different kinds of fermented milk in spontaneously hypertensive rats. Biosci Biotech Biochem 58: 776.
69. Yamamoto N, Akino A, Takano T. 1993. Purification and specifi city of a cell-wall-associated proteinase from Lactobacillus helveticus CP790. J Biochem 114: 740.
70. Yamamoto N, Takano T. 1999. Antihypertensive peptides derived from milk proteins. Nahrung 43: 159.
71. Yang HYT, Erdös EG, Levin Y. 1970. A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochem Biopys Acta 214: 374.
72. Yokoyama K, Chiba H, Yoshikawa M. 1992. Peptide inhibitors for angiotensin I-converting enzyme from thermolysin digest of dried bonito. Biosci Biotech Biochem 56: 1541.